|
Wednesday, November 16, 2005
Inamed Receives Bid From Allergan
Santa Barbara-based INAMED said yesterday that it has received an unsolicited bid from Allergan to acquire the firm. The bid is worth $1.45 billion in cash and 17.9 million shares of Allergan common stock, worth approx. $3.2 billion in total. The bid pits Allergan against an agreement made in March with Medicis Pharmaceuticals to acquire Inamed for $2.8B in cash and stock. Inamed's board has authorized management to consider the offer from Allergan.
posted on Wednesday, November 16, 2005
|
 RSS
 Email
Twitter
Previous news:
Wednesday, December 3, 2008
Tuesday, December 2, 2008
Monday, December 1, 2008
Wednesday, November 26, 2008
Tuesday, November 25, 2008
|
